Locus Pharmaceuticals Enters into Research Collaboration

Locus Pharmaceuticals announced today that it has entered into a discovery research collaboration with Novartis. Locus will collaborate with Novartis to discover novel chemotypes on targets of interest to Novartis' select therapeutic areas.

"We are very excited about the opportunity to work with such a prominent pharmaceutical company to enhance their drug discovery efforts using the Locus technology," said Dr. Joan Lau, President of Locus Pharmaceuticals. "The strength of the Locus discovery process lies not just with the technology, but also the integrated drug design team approach, uniquely customized for each project," she added.